TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 OVERVIEW OF NORTH AMERICA RADIOTHERAPY MARKET
1.3 CURRENCY AND PRICING
1.3.1 LIMITATION
1.3.2 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 GROWING INCIDNECE OF CANCER
3.1.2 RISING AGEING POPULATION
3.1.3 UNHEALTHY LIFESTYLE
3.1.4 MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.2 RESTRAINTS
3.2.1 REGULATORY SCENARIO
3.2.2 HIGH COST OF RADIOTHERAPY
3.3 OPPORTUNITIES
3.3.1 EMERGING MARKET
3.4 CHALLENGES
3.4.1 SIDE-EFFECTS OF RADIOTHERAPY
3.4.2 REQUIREMENT OF TRAINED STAFF
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 INCREASING GOVERNMENT FUNDING AND TECHNOLOGICAL ADVANCEMENT IS EXPECTED TO DRIVE THE MARKET FOR RADIOTHERAPY IN THE FORECAST PERIOD 2018 TO 2025
6 NORTH AMERICA RADIOTHERAPY MARKET, BY THERAPY TYPE
6.1 OVERVIEW
6.2 BEAM RADIOTHERAPY
6.2.1 IGRT
6.2.2 IMRT
6.2.3 STEREOTACTIC TECHNOLOGY
6.2.4 TOMOTHERAPY
6.2.5 3D CONFORMAL RADIOTHERAPY
6.2.6 VMAT
6.3 BRACHYTHERAPY
6.3.1 LDR
6.3.2 HDR
6.4 SYSTEMIC RADIOTHERAPY
7 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 EXTERNAL BEAM RADIOTHERAPY
7.2.1 LINAC
7.2.2 CYBER KNIFE
7.2.3 PROTON THERAPY
7.2.3.1 CYCLOTRON
7.2.3.2 SYNCLOTRON
7.2.4 GAMMA KNIFE
7.3 INTERNAL RADIOTHERAPY PRODUCTS
7.3.1 SEEDS
7.3.2 AFTERLOADERS
7.4 RADIOTHERAPY SOFTWARE
7.4.1 TREATMENT PLANNING SOFTWARE
7.4.2 DOSAGE PLANNING SOFTWARE
7.4.3 PATIENT POSITIONING SOFTWARE
7.4.4 IMAGE GUIDING SOFTWARE
7.5 SYSTEMIC RADIOTHERAPY
8 NORTH AMERICA RADIOTHERAPY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PROSTATE CANCER
8.3 BREAST CANCER
8.4 LUNG CANCER
8.5 SPINE CANCER
8.6 LIVER CANCER
8.7 BRAIN CANCER
8.8 OTHERS
9 NORTH AMERICA RADIOTHERAPY MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
10 NORTH AMERICA RADIOTHERAPY MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS; NORTH AMERICA
11 COMPANY PROFILES
11.1 VARIAN MEDICAL SYSTEMS, INC.
11.1.1 COMPANY OVERVIEW
11.1.2 REVENUE ANALYSIS
11.1.3 PRODUCT PORTFOLIO
11.2 ELEKTA AB
11.2.1 COMPANY OVERVIEW
11.2.2 REVENUE ANALYSIS
11.2.3 PRODUCT PORTFOLIO
11.2.4 RECENT DEVELOPMENTS
11.3 ACCURAY, INC.
11.3.1 COMPANY OVERVIEW
11.3.2 REVENUE ANALYSIS
11.3.3 PRODUCT PORTFOLIO
11.3.4 RECENT DEVELOPMENTS
11.4 BRAINLAB AG
11.4.1 COMPANY OVERVIEW
11.4.2 PRODUCT PORTFOLIO
11.4.3 RECENT DEVELOPMENTS
11.5 ION BEAM APPLICATIONS SA
11.5.1 COMPANY OVERVIEW
11.5.2 REVENUE ANALYSIS
11.5.3 PRODUCT PORTFOLIO
11.5.4 RECENT DEVELOPMENTS
?
11.6 ISORAY MEDICAL, INC.
11.6.1 COMPANY OVERVIEW
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENTS
11.6.4 RECENT DEVELOPMENTS
11.7 MEVION MEDICAL SYSTEMS, INC.
11.7.1 COMPANY OVERVIEW
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 NANOBIOTIX
11.8.1 COMPANY OVERVIEW
11.8.2 REVENUE ANALYSIS
11.8.3 PRODUCT PORTFOLIO
11.8.4 RECENT DEVELOPMENTS
11.9 NORDION (CANADA) INC.
11.9.1 COMPANY OVERVIEW
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENTS
11.10 PRECISIS AG
11.10.1 COMPANY OVERVIEW
11.10.2 PRODUCT PORTFOLIO
11.10.3 RECENT DEVELOPMENTS
11.11 RAYSEARCH LABORATORIES AB
11.11.1 COMPANY OVERVIEW
11.11.2 REVENUE ANALYSIS
11.11.3 PRODUCT PORTFOLIO
11.11.4 RECENT DEVELOPMENTS
12 RELATED REPORTS